当前位置:首页 > 股票大全 > 重药控股 000950 财务分析

重药控股财务分析

整理编辑:168股票行情网www.gphq168.com    数据来源:互联网 经供参考

重药控股(000950)利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入19,624,282,945.1780,119,107,345.0758,383,740,304.6740,715,036,035.64
营业总成本19,384,577,382.479,031,580,193.4557,465,742,981.8939,909,738,668.38
营业利润173,133,845.711,007,094,833.12788,048,801.4747,234,543.61
利润总额174,736,429.141,008,540,696.03794,733,136.46755,738,953.21
净利润134,762,927.5772,499,078.01623,281,816.15629,081,188.22
其他综合收益--41,479,914.34528,045.44555,566.09
综合收益总额134,762,927.5731,019,163.67623,809,861.59629,636,754.31
重药控股(000950)资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计55,807,192,032.7254,576,699,681.6556,398,207,617.6155,421,712,602
非流动资产合计9,016,211,003.218,946,979,900.228,654,216,542.538,569,861,905.67
资产总计64,823,403,035.9363,523,679,581.8765,052,424,160.1463,991,574,507.67
流动负债合计42,264,762,20742,860,428,075.4844,651,621,727.9646,319,415,390.99
非流动负债合计6,920,537,273.365,155,886,955.294,954,076,471.454,091,861,269.84
负债合计49,185,299,480.3648,016,315,030.7749,605,698,199.4150,411,276,660.83
归属于母公司股东权益合计11,348,822,068.611,245,861,308.1211,013,374,544.511,112,779,580.02
股东权益合计15,638,103,555.5715,507,364,551.115,446,725,960.7313,580,297,846.84
负债和股东权益合计64,823,403,035.9363,523,679,581.8765,052,424,160.1463,991,574,507.67
重药控股(000950)现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计20,601,936,509.6583,619,654,919.2161,474,924,015.6939,126,779,812.1
经营活动现金流出小计23,753,295,785.5583,111,120,644.3964,441,722,382.9142,943,605,679.83
经营活动产生的现金流量净额-3,151,359,275.9508,534,274.82-2,966,798,367.22-3,816,825,867.73
投资活动现金流入小计17,691,038.21145,263,344.93129,733,219.96122,799,808.09
投资活动现金流出小计63,322,337.81503,647,659.96341,582,696.95252,255,006.22
投资活动产生的现金流量净额-45,631,299.6-358,384,315.03-211,849,476.99-129,455,198.13
筹资活动现金流入小计5,854,431,253.7828,413,892,027.5121,112,911,978.7514,240,697,370.47
筹资活动现金流出小计6,271,147,497.728,161,399,810.4219,060,273,057.4311,104,866,842.67
筹资活动产生的现金流量净额-416,716,243.92252,492,217.092,052,638,921.323,135,830,527.8
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-3,613,706,819.42402,642,176.88-1,126,008,922.89-810,450,538.06
期末现金及现金等价物余额1,494,142,829.925,107,849,649.343,579,198,549.573,894,756,934.4
重药控股000950相关数据
今日股市大盘指数